![Nancy Valente](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy Valente
Direttore/Membro del Consiglio presso
Myovant Sciences GmbH
Patrimonio netto: 350 757 $ in data 31/05/2026
Profilo
Nancy Valente currently works at Myovant Sciences GmbH, as Director.
Dr. Valente also formerly worked at Myovant Sciences Ltd., as Independent Director from 2021 to 2023, Immatics NV, as Non-Executive Director from 2022 to 2023, Genentech, Inc., as Vice President-Global Hematology Development, Roche Pharmaceuticals, Inc., as SVP & Lead-Global Product Development from 2019 to 2021, Xencor, Inc., as Chief Development Officer & Executive VP from 2023 to 2025, and Anosys, Inc., as Vice President-Clinical Development from 1998 to 2001.
Dr. Valente received her undergraduate degree and doctorate degree from the University of Missouri.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
XENCOR, INC. 0,04% | 28/02/2026 | 29.525 ( 0,04% ) | 350 757 $ | 31/05/2026 |
Posizioni attive di Nancy Valente
| Società | Posizione | Inizio |
|---|---|---|
Myovant Sciences GmbH
 Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Nancy Valente
| Società | Posizione | Fine |
|---|---|---|
| XENCOR, INC. | Direttore/Membro del Consiglio | 01/05/2023 |
| IMMATICS N.V. | Direttore/Membro del Consiglio | 12/05/2023 |
| MYOVANT SCIENCES LTD. | Direttore/Membro del Consiglio | 10/03/2023 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01/06/2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formazione di Nancy Valente
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines infectious diseases and cancer | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
